BOSTON--(BUSINESS WIRE)--July 10, 2006--HepaLife Technologies, Inc. (OTCBB:HPLF - News): Worldwide License Agreement Supported by 5 Issued Patents for the Development of New Flu Vaccines to Protect against the Spread of Influenza Viruses among Humans, Including Potentially the High Pathogenicity H5N1 Virus.
